RWD20 Analysis of US Real World Evidence Data to Assess and Compare the Effectiveness of Two Chemotherapy Regimens: FOLFIRINOX Vs Gemcitabine/Nab-paclitaxel for First Line Metastatic Pancreatic Cancer
Abstract
Authors
K Bocheńska M. Galusza J.P Hodge M.D. Raupp S. Zeng